Bullish indicating open at $55-$60, IPO prices at $37
Investing.com - Centogene reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Centogene announced earnings per share of €-0.353 on revenue of €11.71M. Analysts polled by Investing.com EPS of €-0.382 on revenue of €12.84M.
Centogene 's are down 28.95% and is trading at €1.200 , still down 89.18% from its 52 week high of €11.09 set on Thursday, September 30, 2021.
Centogene follows other major Healthcare sector earnings this month
Centogene's report follows an earnings beat by Merck ADR on Friday, September 9, 2022, who reported EPS of €0.5392 on revenue of €5.69B, EPS of €0.5165 on revenue of €5.57B.
Veeva Systems A had beat expectations on Wednesday, August 31, 2022 with second quarter EPS of €1.03 on revenue of €534.22M, for EPS of €1.01 on revenue of €530.71M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar